作者：
Roche, Nicolas [1]
;
Scheuch, Gerhard [2]
;
Pritchard, John N. [3]
;
Nopitsch-Mai, Cornelia [4]
;
Lakhani, Deepika A. [5]
;
Saluja, Bhawana [6]
;
Jamieson, Janine [7]
;
Dundon, Andrew [8]
;
Wallace, Roisin [9]
;
Holmes, Susan [10]
;
Cipolla, David [11]
;
Dolovich, Myrna B. [12]
;
Shah, Samir A. [13]
;
Lyapustina, Svetlana [14]
作者单位：
Aradigm, Hayward, CA USA
[1]
Drinker Biddle & Reath LLP, 1500 K St NW, Washington, DC 20005 USA
[2]
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA
[3]
Bundesinst Arzneimittel & Med Prod BfArM, Bonn, Germany
[4]
US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD USA
[5]
Philips Respiron, Tangmere, W Sussex, England
[6]
GlaxoSmtithKline, Res Triangle Pk, NC USA
[7]
Teva, W Chester, PA USA
[8]
McMaster Univ, Dept Med, Hamilton, ON, Canada
[9]
Med & Healthcare Prod Regulatory Agcy, London, England
[10]
Hop Cochin, AP HP, Paris, France
[11]
Ventaleon GmbH, Gemunden, Germany
[12]
GlaxoSmithKline, Ware, Herts, England
[13]
Mylan, Dublin, Ireland
[14]
发布时间
2017-11-22
换一批
换一批
